158 filings
Page 2 of 8
8-K
LTRN
Lantern Pharma Inc
24 Nov 23
Entry into a Material Definitive Agreement
4:05pm
10-Q
2023 Q3
LTRN
Lantern Pharma Inc
Quarterly report
8 Nov 23
4:05pm
8-K
LTRN
Lantern Pharma Inc
8 Nov 23
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
LTRN
Lantern Pharma Inc
20 Oct 23
Other Events
5:25pm
10-Q
2023 Q2
LTRN
Lantern Pharma Inc
Quarterly report
9 Aug 23
4:05pm
8-K
LTRN
Lantern Pharma Inc
9 Aug 23
Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
LTRN
Lantern Pharma Inc
21 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
LTRN
Lantern Pharma Inc
9 May 23
Lantern Pharma Reports First Quarter 2023 Financial Results and Operational Highlights
4:05pm
10-Q
2023 Q1
LTRN
Lantern Pharma Inc
Quarterly report
9 May 23
4:05pm
ARS
2022 FY
LTRN
Lantern Pharma Inc
5 May 23
Annual report to shareholders
9:35am
DEF 14A
LTRN
Lantern Pharma Inc
Definitive proxy
27 Apr 23
8:22pm
10-K
2022 FY
LTRN
Lantern Pharma Inc
Annual report
20 Mar 23
4:05pm
8-K
LTRN
Lantern Pharma Inc
20 Mar 23
Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights
4:05pm
8-K
LTRN
Lantern Pharma Inc
18 Jan 23
Departure of Directors or Certain Officers
4:30pm
SC 13G
PRPH
ProPhase Labs Inc
21 Nov 22
Lantern Pharma / ProPhase Labs ownership change
4:15pm
4
Leslie W. Kreis
9 Nov 22
Lantern Pharma / Leslie W. Kreis ownership change
9:39pm
4
BIOS Capital Management, LP
9 Nov 22
Lantern Pharma / Aaron G.L. Fletcher ownership change
9:37pm
10-Q
2022 Q3
LTRN
Lantern Pharma Inc
Quarterly report
7 Nov 22
4:05pm
8-K
LTRN
Lantern Pharma Inc
7 Nov 22
Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights
4:05pm
4
LTRN
Lantern Pharma Inc
24 Oct 22
Lantern Pharma / Maria-Luisa Maccecchini ownership change
5:57pm